全文获取类型
收费全文 | 714篇 |
免费 | 55篇 |
国内免费 | 1篇 |
出版年
2024年 | 1篇 |
2023年 | 8篇 |
2022年 | 24篇 |
2021年 | 43篇 |
2020年 | 46篇 |
2019年 | 85篇 |
2018年 | 67篇 |
2017年 | 28篇 |
2016年 | 30篇 |
2015年 | 38篇 |
2014年 | 33篇 |
2013年 | 54篇 |
2012年 | 57篇 |
2011年 | 35篇 |
2010年 | 16篇 |
2009年 | 23篇 |
2008年 | 23篇 |
2007年 | 39篇 |
2006年 | 19篇 |
2005年 | 28篇 |
2004年 | 15篇 |
2003年 | 12篇 |
2002年 | 5篇 |
2001年 | 10篇 |
2000年 | 3篇 |
1999年 | 6篇 |
1998年 | 1篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1995年 | 2篇 |
1992年 | 3篇 |
1991年 | 5篇 |
1990年 | 2篇 |
1986年 | 1篇 |
1984年 | 1篇 |
1973年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有770条查询结果,搜索用时 15 毫秒
41.
42.
43.
Arezoo G. Shabgah Zhaleh Shariati-Sarabi Jalil Tavakkol-Afshari Mojgan Mohammadi 《Journal of cellular physiology》2019,234(10):17050-17063
Development and activation of B cells quickly became clear after identifying new ligands and receptors in the tumor necrosis factor superfamily. B cell–activating factor (BAFF) and a proliferation-inducing ligand (APRIL) are the members of membrane proteins Type 2 family released by proteolytic cleavage of furin to form active, soluble homotrimers. Except for B cells, ligands are expressed by all such immune cells like T cells, dendritic cells, monocytes, and macrophages. BAFF and APRIL have two common receptors, namely TNFR homolog transmembrane activator and Ca2+ modulator and CAML interactor (TACI) and B cell–maturation antigen. BAFF alone can also be coupled with a third receptor called BAFFR (also called BR3 or BLyS Receptor). These receptors are often expressed by immune cells in the B-cell lineage. The binding of BAFF or APRIL to their receptors supports B cells differentiation and proliferation, immunoglobulin production and the upregulation of B cell–effector molecules expression. It is possible that the overexpression of BAFF and APRIL contributes to the pathogenesis of autoimmune diseases. In BAFF transgenic mice, there is a pseudo-autoimmune manifestation, which is associated with an increase in B-lymphocytes, hyperglobulinemia, anti-single stranded DNA, and anti-double-stranded DNA antibodies, and immune complexes in their peripheral blood. Furthermore, overexpressing BAFF augments the number of peripheral B220+ B cells with a normal proliferation rate, high levels of Bcl2, and prolonged survival and hyperactivity. Therefore, in this review article, we studied BAFF and APRIL as important mediators in B-cell and discussed their role in rheumatoid arthritis. 相似文献
44.
Arezoo Hosseini Ali Masjedi Behzad Baradaran Mohammad Hojjat-Farsangi Ghasem Ghalamfarsa Enayat Anvari Farhad Jadidi-Niaragh 《Journal of cellular physiology》2019,234(7):9943-9955
Dimethyl fumarate (DMF) is an important oral treatment option for various autoimmune diseases, such as multiple sclerosis (MS) and psoriasis. DMF and its dynamic metabolite, monomethyl fumarate (MMF) are the major compounds that exert therapeutic effects on several pathologic conditions in part, through downregulation of immune responses. The exact mechanism of DMF is yet to be fully understood even though its beneficial effects on the immune system are extensively studied. It has been shown that DMF/MMF can affect various immune cells, which can get involved in both the naive and adaptive immune systems, such as T cells, B cells, dendritic cells, macrophages, neutrophils, and natural killer cells. It is suggested that DMF/MMF may exert their effect on immune cells through inhibition of nuclear factor-κB translocation, upregulation of nuclear factor erythroid-derived 2(E2)-related factor antioxidant pathway, and activation of hydroxyl carboxylic acid receptor 2. In this review, the mechanisms underlying the modulatory functions of DMF or MMF on the main immune cell populations involved in the immunopathogenesis of MS are discussed. 相似文献
45.
Meghdad Abdollahpour-Alitappeh Majid Lotfinia Tohid Gharibi Jalal Mardaneh Behrouz Farhadihosseinabadi Pegah Larki Babak Faghfourian Koushan Sineh Sepehr Kazem Abbaszadeh-Goudarzi Ghasem Abbaszadeh-Goudarzi Behrooz Johari Mohammad Reza Zali Nader Bagheri 《Journal of cellular physiology》2019,234(5):5628-5642
Targeted delivery of therapeutic molecules into cancer cells is considered as a promising strategy to tackle cancer. Antibody–drug conjugates (ADCs), in which a monoclonal antibody (mAb) is conjugated to biologically active drugs through chemical linkers, have emerged as a promising class of anticancer treatment agents, being one of the fastest growing fields in cancer therapy. The failure of early ADCs led researchers to explore strategies to develop more effective and improved ADCs with lower levels of unconjugated mAbs and more-stable linkers between the drug and the antibody, which show improved pharmacokinetic properties, therapeutic indexes, and safety profiles. Such improvements resulted in the US Food and Drug Administration approvals of brentuximab vedotin, trastuzumab emtansine, and, more recently, inotuzumab ozogamicin. In addition, recent clinical outcomes have sparked additional interest, which leads to the dramatically increased number of ADCs in clinical development. The present review explores ADCs, their main characteristics, and new research developments, as well as discusses strategies for the selection of the most appropriate target antigens, mAbs, cytotoxic drugs, linkers, and conjugation chemistries. 相似文献
46.
Mahsa Javadian Tohid Gharibi Najibeh Shekari Meghdad Abdollahpour-Alitappeh Ali Mohammadi Arezoo Hossieni Hamed Mohammadi Tohid Kazemi 《Journal of cellular physiology》2019,234(5):5399-5412
MicroRNAs (miRNAs) regulate several biological and physiological processes in mammalian cells, including cellular proliferation, differentiation, apoptosis, and metabolism. Recent studies have confirmed the alteration of them during the cancer development. Matrix metalloproteinases (MMPs), belonging to the large family of proteases, have also been demonstrated to play crucial roles in tissue remodeling, and to support cancer progression and metastasis. There are several known miRNAs which regulate the MMP family and their expression. The expression profiles of miRNAs involved in MMP regulation, change during cancer progression, and metastasis. The present review focuses on important miRNAs capable of targeting MMPs through direct and indirect interactions during the breast cancer development, progression, and metastasis. 相似文献
47.
Shirin Golabi Aghdam Mehrdad Ebrazeh Maryam Hemmatzadeh Narges Seyfizadeh Arezoo Gowhari Shabgah Gholamreza Azizi Negin Ebrahimi Farhad Babaie Hamed Mohammadi 《Journal of cellular physiology》2019,234(7):9927-9942
Prostate cancer (PCa) is considered the most prevalent malignancy and the second major cause of cancer-related death in males from Western countries. PCa exhibits variable clinical pictures, ranging from dormant to highly metastatic cancer. PCa suffers from poor prognosis and diagnosis markers, and novel biomarkers are required to define disease stages and to design appropriate therapeutic approach by considering the possible genomic and epigenomic differences. MicroRNAs (miRNAs) comprise a class of small noncoding RNAs, which have remarkable functions in cell formation, differentiation, and cancer development and contribute in these processes through controlling the expressions of protein-coding genes by repressing translation or breaking down the messenger RNA in a sequence-specific method. miRNAs in cancer are able to reflect informative data about the current status of disease and this might benefit PCa prognosis and diagnosis since that is concerned to PCa patients and we intend to highlight it in this paper. 相似文献
48.
Soroush M. Z. Maghooli K. Pisheh N. F. Mohammadi M. Soroush P. Z. Tahvilian P. 《Neurophysiology》2019,51(3):180-190
Neurophysiology - A novel method based on EEG nonlinear analysis and analysis of steady-state visual evoked potentials (SSVEPs) has been processed. The EEG phase space is reconstructed, and some... 相似文献
49.
Salehi Maryam Karimzadeh Ghasem Naghavi Mohammad Reza 《Plant Cell, Tissue and Organ Culture》2019,137(3):587-597
Plant Cell, Tissue and Organ Culture (PCTOC) - Artemisinin is an efficient anti-malarial drug and it possesses biological activity against a wide range of cancers. The combined application of two... 相似文献
50.
Zohreh Poursina Asadollah Mohammadi Shadi Zamanian Yazdi Ian Humpson Veda Vakili Reza Boostani Houshang Rafatpanah 《Journal of cellular biochemistry》2019,120(9):15740-15745
Human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) disease is a chronic neuroinflammatory disease, which is associated with HTLV-1 infection. There is no effective and satisfactory treatment of HAM/TSP. It has been shown that curcumin exhibits modulatory effects on apoptosis and cytotoxicity-related molecules in HAM/TSP patients. In the present study, we examined the effect of curcumin on the gene expression of caspase-8, caspase-10, and anti-apoptotic protein c-FLIP, in HAM/TSP patients. Furthermore, we compared the expression of these molecules between HAM/TSP and asymptomatic carriers. Real-time PCR was performed to examine the mRNA expression of caspase-8, caspase-10, and c-FLIP in studied groups. The mRNA expression of caspase-8 and caspase-10 was similar before and after curcumin treatment in HAM/TSP patients (P > 0.05). The mRNA expression of c-FLIPL and c-FLIPs was higher after curcumin treatment compared with before treatment and significant differences were observed between the two groups (P = 0.004 and P = 0.044, respectively). The mRNA expression levels of caspase-8, caspase-10, c-FLIPL, and c-FLIPs were not statistically significant between HAM/TSP patients and asymptomatic carriers (P < 0.05). In conclusion, our results showed that curcumin increased the expression of c-FLIP in HAM/TSP patients which might suggest that, this molecule is involved in the apoptosis of HTLV-1-infected cells. Further studies with large sample size could be useful to clarify the role of this supplement in HAM/TSP patients. 相似文献